Welcome : Guest

Merus Labs International, Inc. (Canada) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Merus Labs International, Inc., which is principally involved in the Acquisition and Licensing of Branded Prescription Pharmaceutical Products. Illustrated with 21 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-64888
Price: $1050
Company Type: Public
Pages: 25
Date: November 2016
Market Data Tables: 21

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Merus Labs International, Inc.'s Sales by Geographic Region Worldwide (2013-2014) in Percentage for Canada and International......4
Table 2: Merus Labs International, Inc.’s Sales by Geographic Region Worldwide (2014-2015) in Percentage for Canada, and International......5
Table 3: Merus Labs International, Inc.’s Sales by Product Category Worldwide (2015) in Percentage for Enablex/Emselex, Sintrom, Salagen, Vancocin, and Estraderm......6
Urinary Incontinence Drugs......7
Table 4: Urinary Incontinence Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anticholinergic Agents, and Newer Therapies......7
Table 5: Urinary Incontinence Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Detrol, Detrol LA (PFE), Newer Therapies (ACT, AGN, PFE), Oxybutinin, and Others (Generics)......8
Women's Health Drugs......9
Table 6: Women's Health Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Contraceptives, Hormone Therapy, Fertility, and Others......9
Anticoagulants......10
Table 7: Coagulation Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Hemaphillia A, Hemaphillia B, Inhibitor Bleed Treatment, and Von Willebrand Disease (VWD)......10
Table 8: Anticoagulant Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Heparin, Low-Molecular-Weight Heparin (LMWH), Novel Oral Anticoagulants, Warfarin, and Other Injectable Anticoagulants......11
Table 9: Anticoagulation Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Direct Thrombin Inhibitors (DTI), Low-Molecular-Weight Heparin (LMWH), Unfractionated Heparin (UFH), Vitamin K Antagonists (VKA) and Others......12
Table 10: Anticoagulation Therapy by Segment Worldwide (2015) - Percentage Market Share Breakdown by Value for Acute Coronary Syndrome and Myocardial Infarction, Prevention of Venous Thromboembolism, Stroke Prevention in Atrial Fibrillation, Venous Thromboembolism Treatment and Other Primary Prevention......13
Prescription Pharmaceuticals......14
Table 11: Market Shares of Leading RX Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Eurofarma Laboratórios, Hypermarcas S.A.,Pfizer, Inc., Roche AG, Sanofi - Medley Indústria Farmacêutica Ltda and Others......14
Table 12: Market Shares of Leading Prescription Pharmaceutical Companies in Indonesia (2015) - Percentage Breakdown by Volume Sales for Dexa Medica Group, Interbat Pharmaceutical Industry PT, PT Kalbe Farma, Tbk, PT Sanbe Farma, and Others......15
Table 13: Market Shares of Leading Prescription Pharmaceutical Companies in the US (2014) - Percentage Market Share Breakdown by Volume Sales for Actavis Plc, Amneal, Inc., Endo Pharma, Inc., Lupin Pharmaceuticals, Inc., Mylan Labs,Inc., Novartis International AG, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and Others......16
Table 14: Market Shares of Leading Prescription Drug Companies in the US (2014) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries, Ltd., and Others......17
Table 15: Market Shares of Leading Prescription Drug Companies Spending through Media Ads in the US (2014) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., and Others......18
Urinary Incontinence Therapeutics......19
Table 16: Market Shares of Leading Urinary Incontinence Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Eli Lilly and Company, Johnson & Johnson, Novartis AG, Pfizer, Inc., and Others......19
Women's Health Therapeutics......20
Table 17: Market Shares of Leading Women's Health Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Merck Ltd., Novo Nordisk A/S, Pfizer, Inc., and Others......20
Osteoporosis, Hormone Replacement, & Cancer Bone Loss Medicine......21
Table 18: Market Shares of Leading Osteoporosis, Hormone Replacement, & Cancer Bone Loss Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Amgen, Inc. (AMGN), Eli Lilly And Co (LLY), Merck & Co., Inc. (MRK), Novartis AG (NVS), Sanofi SA (SNY), Warner Chilcott Plc (WCRX), and Others......21
Anti-Infectives......22
Table 19: Market Shares of Leading Anti-Infective Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Bayer AG, Merck & Co., Inc., Vétoquinol S.A., Virbac S.A., Zoetis, Inc. and Others......22
Table 20: Merus Labs International, Inc.'s Drug Sales by Product (2015) - Percentage Share Breakdown by Value for Enablex, Salagen and Estraderm, Sintrom, and Vancocin......23
Table 21: Merus Labs International, Inc.’s Revenues by Prescription (2015) - Percentage Share Breakdown by Volume for Blockbuster Drugs, Mid-Sized Drugs and Small Drugs......24